Sai Life Sciences Limited Reports Revenue growth of 77% YoY

HYDERABAD, India, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, Contract Research, Development and Manufacturing Organization (CRDMO) announced its financial results for the first quarter of Fiscal year 2026.

Financial Performance:

Particulars (₹ crores)

Q1FY26

Q1FY25

YoY%

FY25

FY24

YoY%

Revenue from Operations

496

280

77%

1695

1,465

16%

EBITDA

125

31

303%

425

300

42%

EBITDA Margin%

25%

11%

-

25%

20%

-